# A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

> **NCT04722523** · PHASE1 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Cancer
- Head Cancer
- Head Cancer Neck
- Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- HNSCC

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Docetaxel
- **DRUG:** Cetuximab
- **DRUG:** Cemiplimab
- **PROCEDURE:** Surgical Resection of Primary +/- Neck Dissection
- **RADIATION:** Post-operative radiation therapy
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT04722523
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-20
- **Primary completion:** 2026-06-20
- **Final completion:** 2026-06-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04722523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04722523, "A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04722523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*